Answers are grounded in this paper and cite their sources.
The aims of this study are twofold: (i) to pay tribute to Hartmann Stahelin for his scientific research on cyclosporin A; and (ii) to consider possible lessons for future pharmacological innovation by revisiting Stahelin's personal struggles to obtain fair recognition for his contribution to transplantation medicine.
No takes yet. Share an insight, caveat, or question.
Myra Cheng (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: